• Acetyl-CoA;
  • ADP-ribosylation;
  • calcium signalling;
  • compartmentation;
  • deacetylation;
  • NAD biosynthesis;
  • posttranslational modification;
  • sirtuins


  1. Top of page
  2. Abstract
  3. Introduction
  4. NAD+-dependent protein deacetylation – global regulation of mitochondrial metabolism
  5. SIRT3 – the mitochondrial deacetylase
  6. SIRT5 – the mitochondrial de-acyl-ase
  7. Mitochondrial protein ADP-ribosylation
  8. Mitochondrial NAD-derived calcium messengers – synthesis of cADPR and NAADP
  9. Mitochondrial ADPR metabolism
  10. Establishment and maintenance of the mitochondrial NAD pool
  11. Conclusion and outlook
  12. Acknowledgements
  13. References

Mitochondrial metabolism is intimately connected to the universal coenzyme NAD. In addition to its role in redox reactions of energy transduction, NAD serves as substrate in regulatory reactions that lead to its degradation. Importantly, all types of the known NAD-consuming signalling reactions have been reported to take place in mitochondria. These reactions include the generation of second messengers, as well as post-translational protein modifications such as ADP-ribosylation and protein deacetylation. Therefore, the availability and redox state of NAD emerged as important factors in the regulation of mitochondrial metabolism. Molecular mechanisms and targets of mitochondrial NAD-dependent protein deacetylation and mono-ADP-ribosylation have been established, whereas poly-ADP-ribosylation and NAD-derived messenger generation in the organelles await in-depth characterization. In this review, we highlight the major NAD-dependent reactions occurring within mitochondria and describe their metabolic and regulatory functions. We also discuss the metabolic fates of the NAD-degradation products, nicotinamide and ADP-ribose, and how the mitochondrial NAD pool is restored.




ADP-ribosylhydrolase 3


carbamoylphosphate synthase 1


General control of amino acid synthesis protein 5-like 1


glutamate dehydrogenase


NAD+ glycohydrolase


nicotinamide mononucleotide


NMN adenylyltransferase


nucleoside diphosphate-linked moiety X






reactive oxygen species


transient receptor potential cation channel 2


urate oxidase


  1. Top of page
  2. Abstract
  3. Introduction
  4. NAD+-dependent protein deacetylation – global regulation of mitochondrial metabolism
  5. SIRT3 – the mitochondrial deacetylase
  6. SIRT5 – the mitochondrial de-acyl-ase
  7. Mitochondrial protein ADP-ribosylation
  8. Mitochondrial NAD-derived calcium messengers – synthesis of cADPR and NAADP
  9. Mitochondrial ADPR metabolism
  10. Establishment and maintenance of the mitochondrial NAD pool
  11. Conclusion and outlook
  12. Acknowledgements
  13. References

Mitochondria are vital organelles that carry out important functions in almost all eukaryotic cells. They contain their own genetic material and protein translation machinery and possess two membranes which enclose specialized subcompartments. The mitochondrial matrix, the lumen enclosed by the inner mitochondrial membrane, accommodates enzymes of key metabolic pathways including Krebs cycle, β-oxidation of fatty acids, amino acid catabolism and the urea cycle. Mitochondria are the major site of energy transduction and ATP production as the oxidative phosphorylation machinery is embedded in the inner mitochondrial membrane. Given the central role of mitochondria in energy metabolism, their dysfunction has been associated with various diseases including neurodegenerative disorders, diabetes and cancer [1-3].

Many mitochondrial processes depend on the universal coenzyme nicotinamide adenine dinucleotide (NAD) or its phosphorylated counterpart NADP (Fig. 1). The redox reactions involve the reversible hydride transfer at the nicotinamide moiety of NAD(P), resulting in a switch between oxidized (NAD+, NADP+) and reduced (NADH, NADPH) forms of the nucleotides (Fig. 1). Mitochondria usually contain a major portion of the cellular NAD content, with up to 70% of the cellular pool, depending on tissue and cell type [4, 5]. Mitochondrial oxidative metabolism results in a rather low NAD+/NADH ratio of ~ 7–8 compared with the cytosolic redox ratio of up to 700 [5]. Therefore, both the availability and redox state of NAD have a pronounced influence on all major mitochondrial metabolic processes (Fig. 2).


Figure 1. Structures of NAD and its derivatives. NAD contains the nicotinamide ring (purple box) and ADPR (yellow box). NADP is generated by phosphorylation of NAD at the C2′-position of the adenosine moiety (P; red circle). Electron transfer in redox reactions takes place at the nicotinamide ring (e; blue circle) of both NAD and NADP. Generation of all signalling intermediates involves cleavage of the bond between nicotinamide and ADPR. NAD-dependent protein deacetylation reactions yield OAADPR by transfer of an acetyl group (Ac; green circle) from the acetylated protein onto the terminal ribose. Note that some sirtuins also transfer acyl groups other than acetyl resulting in the formation of the corresponding OAADPR. Under physiological conditions, the acetyl group isomerizes primarily between the C2″ and C3″ positions. Protein mono- and poly-ADP-ribosylation establish a bond between the anomeric carbon (C1″) and the respective ADPR acceptor site (M/P; brown circle). NADases generate the calcium messengers NAADP from NADP by base exchange of nicotinamide to nicotinic acid (dark blue) and cyclic ADPR by cyclization (dashed line) between the anomeric carbon of the terminal ribose and the N1 of the adenine ring.

Download figure to PowerPoint


Figure 2. NAD and ADPR metabolism in mitochondria. NAD is involved in all major metabolic pathways in mitochondria. The oxidized form, NAD+, is reduced to NADH by electron transfer in catabolic reactions such as Krebs cycle and β-oxidation of fatty acids. NAD+ is restored upon electron transfer from NADH to complex I of the electron transport chain during oxidative phosphorylation (OXPHOS). The signalling reactions include protein mono-ADP-ribosylation and protein deacetylation (and -deacylation) and are accompanied by net loss of NAD. Mono-ADP-ribosylation reversibly regulates GDH activity. A second acceptor protein has been reported, but remains unidentified. Protein deacetylation and deacylation by SIRT3 and SIRT5 regulate β-oxidation, the Krebs cycle and OXPHOS via modification of key enzymes in these pathways. Moreover, modification of CPS1 regulates the urea cycle. The level of ROS is controlled via SIRT3-dependent regulation of Mn2+-dependent superoxide dismutase (MnSOD) by SIRT3. Replenishment of the mitochondrial NAD pool may involve NMN import and intramitochondrial conversion to NAD, or direct NAD import. ADPR is the central metabolite emerging from NAD degradation. Sirtuin reactions generate OAADPR, which can be further converted to ADPR by ARH3. Hydrolysis of protein ADPR bonds also yields ADPR. NAD glycohydrolase either generates ADPR directly, or cyclic ADPR, which is eventually hydrolysed to ADPR by the same enzyme. Possible fates of mitochondrial ADPR include the hydrolysis by NUDT9, yielding AMP and ribose-5-phosphate, or export to the cytosol. Once in the cytosol, ADPR may activate TRPM2 calcium channels or undergo degradation by NUDT5.

Download figure to PowerPoint

In addition to participation in redox reactions, NAD is a versatile cellular signalling molecule [6]. All NAD-dependent signalling reactions involve cleavage of the N-glycosidic bond between the nicotinamide ring and the ribose. The remaining ADP-ribose (ADPR) is transferred to an acceptor molecule, which can range from a polypeptide chain to an acyl group or a water molecule, or even the adenine of the ADPR moiety molecule itself in a cyclization reaction (Fig. 1). These reactions comprise the generation of second messenger molecules by the activity of NAD glycohydrolases (NADases) as well as post-translational protein modifications including NAD+-dependent protein deacetylation and mono- and poly-ADP-ribosylation of acceptor proteins.

Although the different types of NAD-dependent signalling reactions do not seem to be present throughout the cell, all of them have been discovered in mitochondria. As outlined below, some of the protein modifications in particular have been intensely studied. For example, protein deacetylation appears to be involved in the regulation of all key metabolic pathways within mitochondria. Therefore, it is not surprising that NAD-dependent signalling pathways are important to maintain mitochondrial function and may become promising targets for the treatment of metabolic diseases.

Because NAD-dependent signalling conversions include cleavage of the nicotinamide moiety, only NAD+, but not NADH, is used as a substrate. In light of the rather low mitochondrial redox ratio, several of the enzymes that catalyse NAD+-dependent signalling reactions have therefore been speculated to be redox sensors detecting the metabolic state of the cell [7, 8].

In this review, we provide an overview over the current knowledge about NAD-dependent signalling in mitochondria and highlight its involvement in processes that are essential for proper mitochondrial function.

NAD+-dependent protein deacetylation – global regulation of mitochondrial metabolism

  1. Top of page
  2. Abstract
  3. Introduction
  4. NAD+-dependent protein deacetylation – global regulation of mitochondrial metabolism
  5. SIRT3 – the mitochondrial deacetylase
  6. SIRT5 – the mitochondrial de-acyl-ase
  7. Mitochondrial protein ADP-ribosylation
  8. Mitochondrial NAD-derived calcium messengers – synthesis of cADPR and NAADP
  9. Mitochondrial ADPR metabolism
  10. Establishment and maintenance of the mitochondrial NAD pool
  11. Conclusion and outlook
  12. Acknowledgements
  13. References

All major mitochondrial processes, such as Krebs cycle, fatty acid metabolism, antioxidant response, oxidative phosphorylation and amino acid catabolism, are regulated by N-ε-lysine acetylation [9-16]. Acetylated lysine residues have been detected in many mitochondrial enzymes and their NAD-dependent deacetylation has been recognized as a key mechanism to control their activities. However, despite its obvious importance, establishment of acetylation marks within mitochondria has not been thoroughly studied. General control of amino acid synthesis protein 5-like 1 (GCN5L1, also known as BLOC1S1), a homologue of the nuclear acetyltransferase GCN5, was suggested to be an indispensable component of the mitochondrial protein acetylation machinery [17]. Knockdown of GCN5L1 was shown to reduce lysine acetylation of mitochondrial fractions, yet this enzyme can account for this modification only in part. Therefore, other acetylation mechanisms need to be considered. For example, earlier reports suggested that nonenzymatic modification might be possible in the presence of high acetyl-CoA concentrations, which may be found in mitochondria [18, 19].

In general, acetylation of mitochondrial enzymes is associated with inhibition of their function, hence, deacetylation serves to activate mitochondrial processes [7, 12, 20]. Deacetylation within mitochondria is primarily carried out by NAD+-dependent deacetylases of the sirtuin family, three of which are located in the mitochondrial matrix (SIRT3–5) [21]. The deacetylation mechanism involves cleavage and release of nicotinamide from NAD+, followed by the transfer of the acetyl moiety from acetylated lysine onto the 2″-position of ADPR, yielding 2″-O-acetyl-ADP-ribose (2″-OAADPR) [22, 23]. The latter can undergo a nonenzymatic transesterification to 3″-OAADPR and to a lesser extent 1″-OAADPR [24]. To date, no function of the acetylated ADPR product in mitochondria has been identified.

It is noteworthy that the three mitochondrial sirtuins belong to different phylogenetic classes within the sirtuin family [25] and in the light of the extended understanding of their enzymatic properties, class-specific functions have been suggested [26, 27]. Whereas SIRT4 and SIRT5 exhibit mono-ADP-ribosyl transferase and deacylase activity, respectively, SIRT3 has emerged as the master regulator of the mitochondrial acetylome (Table 1) [28-31].

Table 1. Functions and targets of mitochondrial sirtuins
Sirtuin (class)aReaction(s)Target(s) and pathway(s)dAssociated effectRef.
  1. a

    Phylogenetic classes according to Frye [25].

  2. b

    First identified to deacetylate CPS1 and later found to have higher desuccinylation activity towards the same protein.

  3. c

    UOX gene is nonfunctional in human and hominoid primates [53].

  4. d

    Abbreviations: AceCS2, acetyl-CoA synthetase 2; CPS1, carbamoylphosphate synthase 1; HMGCS2, 3-hydroxy-3-methylglutaryl-CoA synthase; IDH2, isocitrate dehydrogenase 2; OTC, ornithine carbamoyltransferase; SDH2, succinate dehydrogenase 2; UOX, urate oxidase; (V)LCAD, (very) long-chain acyl-CoA dehydrogenase.

SIRT3 (class Ib)Deacetylation


(Among others, Krebs cycle, acetyl-CoA metabolism, fatty acid oxidation, ROS response and amino acid catabolism)

Activating [9, 10, 12, 16, 33, 35, 37-42, 45-47]
SIRT4 (class II)Mono-ADP-ribosylationGDH (amino acid catabolism)Inactivating [30]
SIRT5 (class III)




CPS1b (urea cycle)Activating [29, 51]
UOXc (purine catabolism) [52]

SIRT3 – the mitochondrial deacetylase

  1. Top of page
  2. Abstract
  3. Introduction
  4. NAD+-dependent protein deacetylation – global regulation of mitochondrial metabolism
  5. SIRT3 – the mitochondrial deacetylase
  6. SIRT5 – the mitochondrial de-acyl-ase
  7. Mitochondrial protein ADP-ribosylation
  8. Mitochondrial NAD-derived calcium messengers – synthesis of cADPR and NAADP
  9. Mitochondrial ADPR metabolism
  10. Establishment and maintenance of the mitochondrial NAD pool
  11. Conclusion and outlook
  12. Acknowledgements
  13. References

Mice knockout studies suggested that SIRT3 is the major mitochondrial protein deacetylase in vivo [14]. Lombard et al. [14] showed that the absence of SIRT3 leads to protein hyperacetylation in mitochondrial fractions of liver and other tissues. This notion was confirmed by mitochondrial acetylome studies that identified more than 1000 SIRT3 targets [12, 16]. Functional association analyses of the identified proteins revealed that SIRT3 is involved in the regulation of all major mitochondrial processes, including maintenance of mtDNA integrity, protection from reactive oxygen species (ROS) and metabolic pathways [12]. Based on this broad spectrum of targets, sirtuins were suggested as sensors for the redox state, to trigger adjustment of metabolic activities [7, 8, 32]. SIRT3 expression levels are elevated under conditions of calorie restriction or prolonged fasting and reduced in response to nutrient excess. The state of mitochondrial protein acetylation changes accordingly [33-36]. The importance of these changes in the acetylome has become more and more apparent over the last years, as critical functional consequences of protein acetylation/deacetylation in mitochondria have been documented.

For example, mitochondrial acetyl-CoA production is stimulated by SIRT3-mediated deacetylation, and hence catalytic activation of very-long-chain- and long-chain-specific acyl-CoA dehydrogenase as well as acetyl-CoA synthase 2 [33, 37-39]. Acetyl-CoA can then enter the Krebs cycle, which is further regulated by SIRT3-dependent deacetylation of succinate dehydrogenase [40, 41]. Alternatively, acetyl-CoA may be utilized for the formation of ketone bodies via SIRT3-activated hydroxymethylglutaryl-CoA synthase [42]. Studies on mouse embryonic fibroblasts from SIRT3−/− mice revealed that electron transport chain complex I is also subject to acetylation-dependent regulation [43, 44]. Furthermore, the amino acid catabolism is stimulated by deacetylation of glutamate dehydrogenase (GDH) [45]. Accumulation of ammonia is prevented by activation of the urea cycle via SIRT3-dependent ornithine carbamoyltransferase deacetylation [14, 46].

In addition to its role in metabolic regulation, SIRT3 can also counteract the accumulation of ROS. This is achieved by deacetylation of isocitrate dehydrogenase 2 and superoxide dismutase leading to the production of NADPH and direct superoxide degradation, respectively [47, 48]. Skeletal-muscle- and liver-specific SIRT3 knockout in mice showed that mild stress conditions neither altered ROS levels nor influenced metabolic homeostasis in comparison with control animals [49]. These observations are in apparent contrast to the results obtained with germline knockout mice [33, 34, 43, 47, 50] and therefore pose questions regarding the mechanism of SIRT3 action, e.g. its tissue specificity, the interplay of multiple tissues or the presence of compensatory mechanisms.

Even though knowledge about SIRT3-dependent deacetylation has expanded rapidly, it has remained elusive why this enzyme has such a broad spectrum of targets. Future studies will have to establish whether SIRT3 activation always leads to a global rearrangement of the mitochondrial acetylome or if there are mechanisms that mediate a more discriminative action, e.g. by directing SIRT3 to specific targets.

SIRT5 – the mitochondrial de-acyl-ase

  1. Top of page
  2. Abstract
  3. Introduction
  4. NAD+-dependent protein deacetylation – global regulation of mitochondrial metabolism
  5. SIRT3 – the mitochondrial deacetylase
  6. SIRT5 – the mitochondrial de-acyl-ase
  7. Mitochondrial protein ADP-ribosylation
  8. Mitochondrial NAD-derived calcium messengers – synthesis of cADPR and NAADP
  9. Mitochondrial ADPR metabolism
  10. Establishment and maintenance of the mitochondrial NAD pool
  11. Conclusion and outlook
  12. Acknowledgements
  13. References

In contrast to SIRT3, the number of known targets for SIRT5 has remained rather limited. However, as described below, SIRT5 appears to preferentially remove acylation marks in proteins other than acetyl groups. Originally, SIRT5 was also suggested to be an NAD+-dependent deacetylase and the first function associated with its activity was the regulation of the urea cycle by deacetylation of carbamoylphosphate synthase 1 (CPS1) [51]. More recently, SIRT5 was found to stimulate purine catabolism in mice via deacetylation of urate oxidase (UOX) [52]. However, UOX is not expressed in hominoid primates including humans [53].

Closer examination of the catalytic properties of SIRT5 revealed a surprisingly weak deacetylation activity [29, 54]. However, this finding is in line with the lack of hyperacetylation in mitochondrial fractions from SIRT5 knockout mice [14]. It turned out that SIRT5 exhibits rather de(acyl)ase activity with higher affinity for malonylated and succinylated targets [29, 31]. In fact, it was demonstrated that CPS1, the identified target of SIRT5, is succinylated in vivo and SIRT5 catalyses the removal of this modification [29]. Analogous to the deacetylation reaction, the deacylation reaction releases O-malonyl-ADPR or O-succinyl-ADPR as products.

For the third mitochondrial member of the sirtuin family, SIRT4, no detectable deacetylation activity could be found [21, 55]. Although this may be due to a very specific substrate spectrum for the deacetylation reaction, another NAD+-dependent enzymatic activity, namely mono-ADP-ribosylation, was identified for SIRT4 [28, 30].

Mitochondrial protein ADP-ribosylation

  1. Top of page
  2. Abstract
  3. Introduction
  4. NAD+-dependent protein deacetylation – global regulation of mitochondrial metabolism
  5. SIRT3 – the mitochondrial deacetylase
  6. SIRT5 – the mitochondrial de-acyl-ase
  7. Mitochondrial protein ADP-ribosylation
  8. Mitochondrial NAD-derived calcium messengers – synthesis of cADPR and NAADP
  9. Mitochondrial ADPR metabolism
  10. Establishment and maintenance of the mitochondrial NAD pool
  11. Conclusion and outlook
  12. Acknowledgements
  13. References

Mono-ADP-ribosylation of proteins designates the transfer of a single ADPR moiety from NAD+ onto an acceptor amino acid residue. In poly-ADP-ribosylation, the protein-bound ADPR moiety serves as target for the attachment of further ADPR units resulting in long, branched polymers containing up to 200 ADPR units.

Mono-ADP-ribosylation in mitochondria has been reported both as enzymatic and nonenzymatic reaction. Enzymatic ADP-ribosylation was shown to preferentially modify cysteine residues in target proteins [56]. GDH, a central enzyme of amino acid metabolism, was identified as the first, and so far only, acceptor protein [57], with cysteine 119 as the major acceptor site [58]. Although GDH is a homohexamer, stochiometric analyses suggested that the modification of a single subunit is sufficient to potently inhibit its enzymatic activity [57]. The ADP-ribosyl transferase mediating the modification was identified as SIRT4 [28, 30]. Thus, in addition to complex allosteric regulation, GDH activity is controlled by two members of the sirtuin family (SIRT4 and SIRT3). Physiologically, the SIRT4-dependent decrease in GDH activity was found to repress amino acid-stimulated insulin secretion [30] both in cell culture systems and mouse SIRT4 knockout models. The recent observation that GDH and SIRT4 antagonistically influence the growth of glial cells corroborates the importance of this regulatory cycle [59]. ADP-ribosylation of GDH is reversible. A Mg2+-dependent ADP-ribosyl cysteine hydrolase activity was detected in mitochondria which removes the modification and restores GDH activity [57]. However, the molecular identity of the enzyme has remained unknown.

Nonenzymatic ADP-ribosylation is chemically distinct from the enzymatic modification and may contribute to the accumulation of advanced glycation end products during aging [60]. Moreover, nonenzymatic mono-ADP-ribosylation of mitochondrial proteins was found to be involved in calcium release from organelles. Treatment with pro-oxidants led to a shift in the mitochondrial redox ratio, the degradation of pyridine nucleotides, generation of ADPR, the modification of a ~ 30 kDa protein by ADP-ribosylation and release of Ca2+ [61]. In a similar way, hormonal control of mitochondria was described. Triiodothyronine is a thyroid hormone that binds to nuclear receptors and influences gene transcription (reviewed in [62, 63]). However, it has long been appreciated that it also acts directly on mitochondria [64-66]. Evidence has been presented suggesting that the effect of triiodothyronine on mitochondrial metabolism may be regulated via mono-ADP-ribosylation of a ~ 30 kDa acceptor protein [67]. The possibility to generate intramitochondrial ADPR, potentially enabling nonenzymatic ADP-ribosylation, was supported by the demonstration of a mitochondrial NAD+ glycohydrolase activity [68].

Poly-ADP-ribosylation has a prominent role in various nuclear processes. Nevertheless, several studies reported mitochondrial poly-ADPR formation or detection of poly-ADP-ribosylated proteins within the organelles [69-71]. However, this subject remains controversial (reviewed in [62, 63]). For example, poly-ADP-ribose polymerase 1 (PARP1), a protein with an undisputed nuclear localization, was partially localized to mitochondria [69, 74]. However, this observation was not confirmed by others [75]. Interestingly, a small isoform of the poly-ADP-ribose (PAR)-degrading enzyme poly-ADP-ribose glycohydrolase (PARG) was proposed to be present in mitochondria [76, 77]. Detailed analyses revealed, however, that this isoform is catalytically inactive [78]. By contrast, ADP-ribosylhydrolase 3 (ARH3) partially localizes to mitochondria [77] and exhibits weak PAR-cleaving activity [77,78]. However, its major activity appears to be hydrolysis of OAADPR to ADPR and acetic acid [79] (see below).

Mitochondrial NAD-derived calcium messengers – synthesis of cADPR and NAADP

  1. Top of page
  2. Abstract
  3. Introduction
  4. NAD+-dependent protein deacetylation – global regulation of mitochondrial metabolism
  5. SIRT3 – the mitochondrial deacetylase
  6. SIRT5 – the mitochondrial de-acyl-ase
  7. Mitochondrial protein ADP-ribosylation
  8. Mitochondrial NAD-derived calcium messengers – synthesis of cADPR and NAADP
  9. Mitochondrial ADPR metabolism
  10. Establishment and maintenance of the mitochondrial NAD pool
  11. Conclusion and outlook
  12. Acknowledgements
  13. References

Cyclic ADPR (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP) are two potent intracellular calcium-mobilizing second messengers. Both molecules are generated by the same class of enzymes, NADases. The best characterized mammalian NADase is the plasma membrane protein CD38 [80]. NAADP is generated by a base-exchange reaction that replaces the nicotinamide ring of NADP with nicotinic acid, whereas cADPR is generated by an intramolecular cyclization of ADPR between N1 of the adenine ring and the anomeric carbon of the terminal ribose following cleavage of the nicotinamide moiety (Fig. 1) [81, 82]. The established enzyme mechanism also accounts for the direct conversion of NAD+ to ADPR, as well as the cleavage of cADPR to ADPR. Mitochondria were repeatedly shown to possess NADase activity, implying that they are able to generate these calcium-mobilizing agents [83-88]. Accordingly, mitochondrial fractions were found capable of synthesizing both cADPR and NAADP [89, 90].

The identity of the mitochondrial NADase has not been established. Liang and colleagues [89] reported that the mitochondrial enzyme activity was distinct from CD38 both by western blot analyses and specific inhibition of the mitochondrial ADP-ribosyl cyclase activity, but not CD38, with Zn2+ ions. However, only two NADases have been found in mammals, CD38 and CD157. Both are plasma membrane proteins and therefore not readily suspected to play a role in intracellular processes. Nevertheless, CD38 has repeatedly been suggested to have intracellular functions [91]. Identification of a bovine mitochondrial NADase, based on partial peptide sequences of a ~ 31 kDa protein, resulted in a perfect match with bovine CD38 protein, whose sequence was not available at the time of the study [92]. However, plasma membrane CD38 has a molecular mass of ~ 45 kDa due to glycosylation of the protein [93, 94]. In fact, the amino acid sequence alone predicts a theoretical mass of ~ 31.5 kDa. The presence of CD38 in mitochondria has been further supported by immunoreactivity towards CD38 associated with mitochondria in rat brain samples [91] and in studies with CD38 knockout mice [95]. Moreover, a truncated CD38 protein lacking the N-terminal tail and transmembrane domain showed predominant localization in mitochondria [96]. The intriguing question remains: is the mitochondrial enzyme a nonglycosylated form of CD38?

Mitochondrial ADPR metabolism

  1. Top of page
  2. Abstract
  3. Introduction
  4. NAD+-dependent protein deacetylation – global regulation of mitochondrial metabolism
  5. SIRT3 – the mitochondrial deacetylase
  6. SIRT5 – the mitochondrial de-acyl-ase
  7. Mitochondrial protein ADP-ribosylation
  8. Mitochondrial NAD-derived calcium messengers – synthesis of cADPR and NAADP
  9. Mitochondrial ADPR metabolism
  10. Establishment and maintenance of the mitochondrial NAD pool
  11. Conclusion and outlook
  12. Acknowledgements
  13. References

Although the NAD-dependent signalling processes differ in their biological roles and molecular mechanisms, they share at least two general features. First, a common step in the modifying reactions is the release of nicotinamide from NAD. That is, all these reactions produce nicotinamide, which in turn may act as inhibitor, at least of sirtuins, NADases and PARPs [97, 98]. However, because nicotinamide is membrane permeable and readily recycled to nicotinamide mononucleotide (NMN) by nicotinamide phosphoribosyltransferase, it is not known whether the inhibition is relevant for endogenously produced nicotinamide. The second property shared is the generation of free ADPR as a result of ‘signal deactivation’ (Fig. 2). Protein mono-ADPR bonds, poly-ADPR, OAADPR and cADPR are cleaved by specific hydrolases to liberate ADPR [79, 99]. ADPR can directly influence mitochondrial metabolism, because it inhibits complex I of the electron transport chain [100]. Consequently, proper disposal of this molecule is important to maintain mitochondrial function.

Evidence has been presented that ADPR can be released from mitochondria and potentially function as a second messenger [101, 102]. Indeed, cytosolic ADPR stimulates Ca2+ signalling by activating the transient receptor potential cation channel 2 (TRPM2) via its C-terminal NUDT9 homology domain (NUDT9-H) [103, 104]. The mechanism of ADPR release from mitochondria is not yet understood. It might involve opening of the mitochondrial permeability transition pore or a hitherto unidentified ADPR transporter [102].

Interestingly, OAADPR itself is also an activating ligand of the TRPM2 channel [105]. Hydrolysis of OAADPR to ADPR within mitochondria is possible due to the enzymatic activity of ADP-ribosyl hydrolase 3 (ARH3) [77, 79, 106]. With the discovery of O-succinyl-ADPR and O-malonyl-ADPR as products of SIRT5 deacylation reactions [29] it is tempting to speculate that ARH3 might also hydrolyse these intermediates. Polymers of ADPR, when artificially generated in mitochondria, are also degraded by ARH3 [77]. By contrast, ARH3 failed to hydrolyse any of the tested protein–ADPR conjugates at cysteine, arginine and aspartate residues [106]. Given the uncertainty regarding endogenous PAR in the organelles and the rather low activity towards the polymers, the major physiological role of ARH3 in mitochondria appears to be the cleavage of OAADPR (or other acylated ADPR derivatives) generated by mitochondrial sirtuins.

In addition, the recently identified mitochondrial macro-domain-containing protein, MacroD1 (also known as LRP16) [107] exhibits OAADPR hydrolase activity [108]. Macro domains are protein modules able to bind NAD metabolites such as OAADPR and ADPR and are found both in the nucleus and mitochondria [109].

ADPR is also subject to further conversion both within mitochondria and the cytosol (Fig. 2). It is cleaved by nucleoside diphosphate-linked moiety X (NUDIX) hydrolases. Members of the NUDIX family often exhibit substrate selectivity for specific nucleotide derivatives [110, 111]. NUDT9, a mitochondrial enzyme with preference for ADPR as substrate, produces ribose-5-phosphate and AMP [112-114]. In the cytosol, ADPR can also be degraded into ribose-5-phosphate and AMP by another NUDIX hydrolase, NUDT5 (Fig. 2) [115].

Establishment and maintenance of the mitochondrial NAD pool

  1. Top of page
  2. Abstract
  3. Introduction
  4. NAD+-dependent protein deacetylation – global regulation of mitochondrial metabolism
  5. SIRT3 – the mitochondrial deacetylase
  6. SIRT5 – the mitochondrial de-acyl-ase
  7. Mitochondrial protein ADP-ribosylation
  8. Mitochondrial NAD-derived calcium messengers – synthesis of cADPR and NAADP
  9. Mitochondrial ADPR metabolism
  10. Establishment and maintenance of the mitochondrial NAD pool
  11. Conclusion and outlook
  12. Acknowledgements
  13. References

The functionality of mitochondrial metabolism is highly dependent on the maintenance of the organellar NAD pool [116, 117]. Given the multitude of NAD-degrading signalling reactions, it can be expected that the turnover of this molecule is significant. Nevertheless, the pathway of mitochondrial NAD generation in mammalian cells is still not fully understood.

Although in Saccharomyces cerevisiae [118] and Arabidopsis thaliana [119] NAD is imported from the cytosol by specific mitochondrial NAD transporters, such a mechanism has not been identified in mammals. In fact, the closest human homologue of these transporters was unable to carry NAD [117], but rather transports folate [120] and FAD [121]. Moreover, whereas the outer mitochondrial membrane is permeable for NAD, in vitro studies on isolated mammalian mitochondria suggested that the inner mitochondrial membrane was indeed impermeable for NAD [5].

A potential alternative to mitochondrial NAD uptake is intraorganellar biosynthesis of the molecule. Indeed, a mammalian isoform of NMN adenylyltransferase (NMNAT), NMNAT3, has been identified [122] and localized to the mitochondrial matrix [123]. NMNATs catalyse the final step of NAD synthesis by forming the dinucleotide from NMN and ATP [124, 125]. Interestingly, neither S. cerevisiae nor A. thaliana have a mitochondrial NMNAT isoform. Consequently, in mammals, generation of mitochondrial NAD might rely on the uptake of NMN from the cytosol. However, a corresponding mitochondrial transporter has not been identified so far. Nevertheless, the ability of isolated rat liver mitochondria to generate NAD from added NMN supports such a possibility [126]. Moreover, it has been recently reported that mitochondria from U937 and HeLa cells contain considerable amounts (1–2 nmol·mg−1 protein) of NMN [127]. Taking further into account that none of the other known NAD-biosynthetic enzymes in mammals localizes to mitochondria [116, 123], it appears plausible that mitochondrial NAD is generated from imported NMN, even though direct NAD uptake from the cytosol cannot be fully ruled out.

Conclusion and outlook

  1. Top of page
  2. Abstract
  3. Introduction
  4. NAD+-dependent protein deacetylation – global regulation of mitochondrial metabolism
  5. SIRT3 – the mitochondrial deacetylase
  6. SIRT5 – the mitochondrial de-acyl-ase
  7. Mitochondrial protein ADP-ribosylation
  8. Mitochondrial NAD-derived calcium messengers – synthesis of cADPR and NAADP
  9. Mitochondrial ADPR metabolism
  10. Establishment and maintenance of the mitochondrial NAD pool
  11. Conclusion and outlook
  12. Acknowledgements
  13. References

The understanding of NAD-dependent processes within mammalian mitochondria has been greatly expanded over recent years revealing an unexpected complexity of regulatory networks that include and combine NAD-dependent post-translational modifications, second messenger generation and redox state. However, several important questions remain elusive. For example, how the mitochondrial NAD pool is established requires further investigation, especially with regard to the mechanisms of NMN or NAD transport into the organelles. Moreover, the existence of mitochondrial poly-ADPR metabolism is still debated and requires clarification. The potential signalling functions, metabolism and export of NAD-derived intermediates also need further investigation. Finally, exploring the possible roles of global acetylation/deacetylation in mitochondria as compared to target-specific regulation of mitochondrial activities by acylation will be a demanding task for the years to come.


  1. Top of page
  2. Abstract
  3. Introduction
  4. NAD+-dependent protein deacetylation – global regulation of mitochondrial metabolism
  5. SIRT3 – the mitochondrial deacetylase
  6. SIRT5 – the mitochondrial de-acyl-ase
  7. Mitochondrial protein ADP-ribosylation
  8. Mitochondrial NAD-derived calcium messengers – synthesis of cADPR and NAADP
  9. Mitochondrial ADPR metabolism
  10. Establishment and maintenance of the mitochondrial NAD pool
  11. Conclusion and outlook
  12. Acknowledgements
  13. References
  • 1
    Lin MT & Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787795.
  • 2
    Schapira AH (2012) Mitochondrial diseases. Lancet 379, 18251834.
  • 3
    Wallace DC (2012) Mitochondria and cancer. Nat Rev Cancer 12, 685698.
  • 4
    Di Lisa F & Ziegler M (2001) Pathophysiological relevance of mitochondria in NAD(+) metabolism. FEBS Lett 492, 48.
  • 5
    Stein LR & Imai S (2012) The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol Metab 23, 420428.
  • 6
    Koch-Nolte F, Fischer S, Haag F & Ziegler M (2011) Compartmentation of NAD+-dependent signalling. FEBS Lett 585, 16511656.
  • 7
    Huang JY, Hirschey MD, Shimazu T, Ho L & Verdin E (2010) Mitochondrial sirtuins. Biochim Biophys Acta 1804, 16451651.
  • 8
    Onyango P, Celic I, McCaffery JM, Boeke JD & Feinberg AP (2002) SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc Natl Acad Sci U S A 99, 1365313658.
  • 9
    Bell EL & Guarente L (2011) The SirT3 divining rod points to oxidative stress. Mol Cell 42, 561568.
  • 10
    Giralt A & Villarroya F (2012) SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging. Biochem J 444, 110.
  • 11
    Guan KL & Xiong Y (2011) Regulation of intermediary metabolism by protein acetylation. Trends Biochem Sci 36, 108116.
  • 12
    Hebert AS, Dittenhafer-Reed KE, Yu W, Bailey DJ, Selen ES, Boersma MD, Carson JJ, Tonelli M, Balloon AJ, Higbee AJ et al. (2013) Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol Cell 49, 186199.
  • 13
    Hirschey MD, Shimazu T, Huang JY, Schwer B & Verdin E (2011) SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism. Cold Spring Harb Symp Quant Biol 76, 267277.
  • 14
    Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, Kim J, Yancopoulos G, Valenzuela D, Murphy A et al. (2007) Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol 27, 88078814.
  • 15
    Peserico A, Chiacchiera F, Grossi V, Matrone A, Latorre D, Simonatto M, Fusella A, Ryall JG, Finley LW, Haigis MC et al. (2013) A novel AMPK-dependent FoxO3A-SIRT3 intramitochondrial complex sensing glucose levels. Cell Mol Life Sci, doi:10.1007/s00018-012-1244-6
  • 16
    Sol EM, Wagner SA, Weinert BT, Kumar A, Kim HS, Deng CX & Choudhary C (2012) Proteomic investigations of lysine acetylation identify diverse substrates of mitochondrial deacetylase sirt3. PLoS ONE 7, e50545.
  • 17
    Scott I, Webster BR, Li JH & Sack MN (2012) Identification of a molecular component of the mitochondrial acetyltransferase programme: a novel role for GCN5L1. Biochem J 443, 655661.
  • 18
    Garland PB, Shepherd D & Yates DW (1965) Steady-state concentrations of coenzyme A, acetyl-coenzyme A and long-chain fatty acyl-coenzyme A in rat-liver mitochondria oxidizing palmitate. Biochem J 97, 587594.
  • 19
    Paik WK, Pearson D, Lee HW & Kim S (1970) Nonenzymatic acetylation of histones with acetyl-CoA. Biochim Biophys Acta 213, 513522.
  • 20
    Green MF & Hirschey MD (2013) SIRT3 weighs heavily in the metabolic balance: a new role for SIRT3 in metabolic syndrome. J Gerontol A Biol Sci Med Sci 68, 105107.
  • 21
    Michishita E, Park JY, Burneskis JM, Barrett JC & Horikawa I (2005) Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 16, 46234635.
  • 22
    Denu JM (2005) The Sir 2 family of protein deacetylases. Curr Opin Chem Biol 9, 431440.
  • 23
    Feldman JL, Dittenhafer-Reed KE & Denu JM (2012) Sirtuin catalysis and regulation. J Biol Chem 287, 4241942427.
  • 24
    Kasamatsu A, Nakao M, Smith BC, Comstock LR, Ono T, Kato J, Denu JM & Moss J (2011) Hydrolysis of O-acetyl-ADP-ribose isomers by ADP-ribosylhydrolase 3. J Biol Chem 286, 2111021117.
  • 25
    Frye RA (2000) Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 273, 793798.
  • 26
    He W, Newman JC, Wang MZ, Ho L & Verdin E (2012) Mitochondrial sirtuins: regulators of protein acylation and metabolism. Trends Endocrinol Metab 23, 467476.
  • 27
    Hirschey MD (2011) Old enzymes, new tricks: sirtuins are NAD(+)-dependent de-acylases. Cell Metab 14, 718719.
  • 28
    Ahuja N, Schwer B, Carobbio S, Waltregny D, North BJ, Castronovo V, Maechler P & Verdin E (2007) Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J Biol Chem 282, 3358333592.
  • 29
    Du J, Zhou Y, Su X, Yu JJ, Khan S, Jiang H, Kim J, Woo J, Kim JH, Choi BH et al. (2011) Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806809.
  • 30
    Haigis MC, Mostoslavsky R, Haigis KM, Fahie K, Christodoulou DC, Murphy AJ, Valenzuela DM, Yancopoulos GD, Karow M, Blander G et al. (2006) SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126, 941954.
  • 31
    Peng C, Lu Z, Xie Z, Cheng Z, Chen Y, Tan M, Luo H, Zhang Y, He W, Yang K et al. (2011) The first identification of lysine malonylation substrates and its regulatory enzyme. Mol Cell Proteomics 10, M111.012658.
  • 32
    Schwer B, Eckersdorff M, Li Y, Silva JC, Fermin D, Kurtev MV, Giallourakis C, Comb MJ, Alt FW & Lombard DB (2009) Calorie restriction alters mitochondrial protein acetylation. Aging Cell 8, 604606.
  • 33
    Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, Grueter CA, Harris C, Biddinger S, Ilkayeva OR et al. (2010) SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464, 121125.
  • 34
    Hirschey MD, Shimazu T, Jing E, Grueter CA, Collins AM, Aouizerat B, Stancakova A, Goetzman E, Lam MM, Schwer B et al. (2011) SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell 44, 177190.
  • 35
    Shi T, Wang F, Stieren E & Tong Q (2005) SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem 280, 1356013567.
  • 36
    Someya S, Yu W, Hallows WC, Xu J, Vann JM, Leeuwenburgh C, Tanokura M, Denu JM & Prolla TA (2010) Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143, 802812.
  • 37
    Chegary M, Brinke H, Ruiter JP, Wijburg FA, Stoll MS, Minkler PE, van Weeghel M, Schulz H, Hoppel CL, Wanders RJ et al. (2009) Mitochondrial long chain fatty acid beta-oxidation in man and mouse. Biochim Biophys Acta 1791, 806815.
  • 38
    Hallows WC, Lee S & Denu JM (2006) Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci U S A 103, 1023010235.
  • 39
    Schwer B, Bunkenborg J, Verdin RO, Andersen JS & Verdin E (2006) Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc Natl Acad Sci U S A 103, 1022410229.
  • 40
    Cimen H, Han MJ, Yang Y, Tong Q, Koc H & Koc EC (2010) Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. Biochemistry 49, 304311.
  • 41
    Finley LW, Haas W, Desquiret-Dumas V, Wallace DC, Procaccio V, Gygi SP & Haigis MC (2011) Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity. PLoS ONE 6, e23295.
  • 42
    Shimazu T, Hirschey MD, Hua L, Dittenhafer-Reed KE, Schwer B, Lombard DB, Li Y, Bunkenborg J, Alt FW, Denu JM et al. (2010) SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab 12, 654661.
  • 43
    Ahn BH, Kim HS, Song S, Lee IH, Liu J, Vassilopoulos A, Deng CX & Finkel T (2008) A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci U S A 105, 1444714452.
  • 44
    Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM et al. (2010) SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17, 4152.
  • 45
    Schlicker C, Gertz M, Papatheodorou P, Kachholz B, Becker CF & Steegborn C (2008) Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol 382, 790801.
  • 46
    Hallows WC, Yu W, Smith BC, Devries MK, Ellinger JJ, Someya S, Shortreed MR, Prolla T, Markley JL, Smith LM et al. (2011) Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Mol Cell 41, 139149.
  • 47
    Qiu X, Brown K, Hirschey MD, Verdin E & Chen D (2010) Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 12, 662667.
  • 48
    Yu W, Lin Y, Yao J, Huang W, Lei Q, Xiong Y, Zhao S & Guan KL (2009) Lysine 88 acetylation negatively regulates ornithine carbamoyltransferase activity in response to nutrient signals. J Biol Chem 284, 1366913675.
  • 49
    Fernandez-Marcos PJ, Jeninga EH, Canto C, Harach T, de Boer VC, Andreux P, Moullan N, Pirinen E, Yamamoto H, Houten SM et al. (2012) Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis. Sci Rep 2, 425.
  • 50
    Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A & Gupta MP (2009) Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 119, 27582771.
  • 51
    Nakagawa T, Lomb DJ, Haigis MC & Guarente L (2009) SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137, 560570.
  • 52
    Nakamura Y, Ogura M, Ogura K, Tanaka D & Inagaki N (2012) SIRT5 deacetylates and activates urate oxidase in liver mitochondria of mice. FEBS Lett 586, 40764081.
  • 53
    Wu XW, Muzny DM, Lee CC & Caskey CT (1992) Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol 34, 7884.
  • 54
    Schuetz A, Bernstein G, Dong A, Antoshenko T, Wu H, Loppnau P, Bochkarev A & Plotnikov AN (2007) Crystal structure of a binary complex between human GCN5 histone acetyltransferase domain and acetyl coenzyme A. Proteins 68, 403407.
  • 55
    North BJ, Marshall BL, Borra MT, Denu JM & Verdin E (2003) The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 11, 437444.
  • 56
    Jorcke D, Ziegler M, Herrero-Yraola A & Schweiger M (1998) Enzymic, cysteine-specific ADP-ribosylation in bovine liver mitochondria. Biochem J 332 (Pt 1), 189193.
  • 57
    Herrero-Yraola A, Bakhit SM, Franke P, Weise C, Schweiger M, Jorcke D & Ziegler M (2001) Regulation of glutamate dehydrogenase by reversible ADP-ribosylation in mitochondria. EMBO J 20, 24042412.
  • 58
    Choi MM, Huh JW, Yang SJ, Cho EH, Choi SY & Cho SW (2005) Identification of ADP-ribosylation site in human glutamate dehydrogenase isozymes. FEBS Lett 579, 41254130.
  • 59
    Komlos D, Mann KD, Zhuo Y, Ricupero CL, Hart RP, Liu AY & Firestein BL (2013) Glutamate dehydrogenase 1 and SIRT4 regulate glial development. Glia 61, 394408.
  • 60
    Jacobson EL, Cervantes-Laurean D & Jacobson MK (1997) ADP-ribose in glycation and glycoxidation reactions. Adv Exp Med Biol 419, 371379.
  • 61
    Richter C & Kass GE (1991) Oxidative stress in mitochondria: its relationship to cellular Ca2+ homeostasis, cell death, proliferation, and differentiation. Chem Biol Interact 77, 123.
  • 62
    Arsanjani R, McCarren M, Bahl JJ & Goldman S (2011) Translational potential of thyroid hormone and its analogs. J Mol Cell Cardiol 51, 506511.
  • 63
    Oetting A & Yen PM (2007) New insights into thyroid hormone action. Best Pract Res Clin Endocrinol Metab 21, 193208.
  • 64
    Goglia F, Torresani J, Bugli P, Barletta A & Liverini G (1981) In vitro binding of triiodothyronine to rat liver mitochondria. Pflugers Arch 390, 120124.
  • 65
    Mowbray J & Hardy DL (1996) Direct thyroid hormone signalling via ADP-ribosylation controls mitochondrial nucleotide transport and membrane leakiness by changing the conformation of the adenine nucleotide transporter. FEBS Lett 394, 6165.
  • 66
    Verhoeven AJ, Kamer P, Groen AK & Tager JM (1985) Effects of thyroid hormone on mitochondrial oxidative phosphorylation. Biochem J 226, 183192.
  • 67
    Thomas WE & Mowbray J (1987) Evidence for ADP-ribosylation in the mechanism of rapid thyroid hormone control of mitochondria. FEBS Lett 223, 279283.
  • 68
    Zhang J, Benovic JL, Sugai M, Wetzker R, Gout I & Rittenhouse SE (1995) Sequestration of a G-protein beta gamma subunit or ADP-ribosylation of Rho can inhibit thrombin-induced activation of platelet phosphoinositide 3-kinases. J Biol Chem 270, 65896594.
  • 69
    Du L, Zhang X, Han YY, Burke NA, Kochanek PM, Watkins SC, Graham SH, Carcillo JA, Szabo C & Clark RS (2003) Intra-mitochondrial poly(ADP-ribosylation) contributes to NAD+ depletion and cell death induced by oxidative stress. J Biol Chem 278, 1842618433.
  • 70
    Du X, Matsumura T, Edelstein D, Rossetti L, Zsengeller Z, Szabo C & Brownlee M (2003) Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 112, 10491057.
  • 71
    Lai Y, Chen Y, Watkins SC, Nathaniel PD, Guo F, Kochanek PM, Jenkins LW, Szabo C & Clark RS (2008) Identification of poly-ADP-ribosylated mitochondrial proteins after traumatic brain injury. J Neurochem 104, 17001711.
  • 72
    Burkle A & Virag L (2013) Poly(ADP-ribose): PARadigms and PARadoxes. Mol Aspects Med, doi: S0098-2997(12)00157-410.1016/j.mam.2012.12.010
  • 73
    Scovassi AI (2004) Mitochondrial poly(ADP-ribosylation): from old data to new perspectives. FASEB J 18, 14871488.
  • 74
    Rossi MN, Carbone M, Mostocotto C, Mancone C, Tripodi M, Maione R & Amati P (2009) Mitochondrial localization of PARP-1 requires interaction with mitofilin and is involved in the maintenance of mitochondrial DNA integrity. J Biol Chem 284, 3161631624.
  • 75
    Lapucci A, Pittelli M, Rapizzi E, Felici R, Moroni F & Chiarugi A (2011) Poly(ADP-ribose) polymerase-1 is a nuclear epigenetic regulator of mitochondrial DNA repair and transcription. Mol Pharmacol 79, 932940.
  • 76
    Meyer RG, Meyer-Ficca ML, Whatcott CJ, Jacobson EL & Jacobson MK (2007) Two small enzyme isoforms mediate mammalian mitochondrial poly(ADP-ribose) glycohydrolase (PARG) activity. Exp Cell Res 313, 29202936.
  • 77
    Niere M, Kernstock S, Koch-Nolte F & Ziegler M (2008) Functional localization of two poly(ADP-ribose)-degrading enzymes to the mitochondrial matrix. Mol Cell Biol 28, 814824.
  • 78
    Niere M, Mashimo M, Agledal L, Dolle C, Kasamatsu A, Kato J, Moss J & Ziegler M (2012) ADP-ribosylhydrolase 3 (ARH3), not poly(ADP-ribose) glycohydrolase (PARG) isoforms, is responsible for degradation of mitochondrial matrix-associated poly(ADP-ribose). J Biol Chem 287, 1608816102.
  • 79
    Ono T, Kasamatsu A, Oka S & Moss J (2006) The 39-kDa poly(ADP-ribose) glycohydrolase ARH3 hydrolyzes O-acetyl-ADP-ribose, a product of the Sir2 family of acetyl-histone deacetylases. Proc Natl Acad Sci U S A 103, 1668716691.
  • 80
    Lee HC (2012) Cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate (NAADP) as messengers for calcium mobilization. J Biol Chem 287, 3163331640.
  • 81
    Lee HC, Aarhus R & Levitt D (1994) The crystal structure of cyclic ADP-ribose. Nat Struct Biol 1, 143144.
  • 82
    Muller-Steffner HM, Augustin A & Schuber F (1996) Mechanism of cyclization of pyridine nucleotides by bovine spleen NAD+ glycohydrolase. J Biol Chem 271, 2396723972.
  • 83
    Frei B & Richter C (1988) Mono(ADP-ribosylation) in rat liver mitochondria. Biochemistry 27, 529535.
  • 84
    Hilz H, Koch R, Fanick W, Klapproth K & Adamietz P (1984) Nonenzymic ADP-ribosylation of specific mitochondrial polypeptides. Proc Natl Acad Sci U S A 81, 39293933.
  • 85
    Lotscher HR, Winterhalter KH, Carafoli E & Richter C (1980) Hydroperoxide-induced loss of pyridine nucleotides and release of calcium from rat liver mitochondria. J Biol Chem 255, 93259330.
  • 86
    Masmoudi A, Islam F & Mandel P (1988) ADP-ribosylation of highly purified rat brain mitochondria. J Neurochem 51, 188193.
  • 87
    Masmoudi A & Mandel P (1987) ADP-ribosyl transferase and NAD glycohydrolase activities in rat liver mitochondria. Biochemistry 26, 19651969.
  • 88
    Richter C, Winterhalter KH, Baumhuter S, Lotscher HR & Moser B (1983) ADP-ribosylation in inner membrane of rat liver mitochondria. Proc Natl Acad Sci U S A 80, 31883192.
  • 89
    Liang M, Chini EN, Cheng J & Dousa TP (1999) Synthesis of NAADP and cADPR in mitochondria. Arch Biochem Biophys 371, 317325.
  • 90
    Ziegler M, Jorcke D & Schweiger M (1997) Identification of bovine liver mitochondrial NAD+ glycohydrolase as ADP-ribosyl cyclase. Biochem J 326 (Pt 2), 401405.
  • 91
    Yamada M, Mizuguchi M, Otsuka N, Ikeda K & Takahashi H (1997) Ultrastructural localization of CD38 immunoreactivity in rat brain. Brain Res 756, 5260.
  • 92
    Zhang J, Ziegler M, Schneider R, Klocker H, Auer B & Schweiger M (1995) Identification and purification of a bovine liver mitochondrial NAD(+)-glycohydrolase. FEBS Lett 377, 530534.
  • 93
    Chidambaram N & Chang CF (1998) Functional role of glycosylation on the recombinant CD38/ADP-ribosyl cyclase in CHO cells. Int J Biochem Cell Biol 30, 10111018.
  • 94
    Jackson DG & Bell JI (1990) Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation. J Immunol 144, 28112815.
  • 95
    Chini EN, Chini CC, Kato I, Takasawa S & Okamoto H (2002) CD38 is the major enzyme responsible for synthesis of nicotinic acid-adenine dinucleotide phosphate in mammalian tissues. Biochem J 362, 125130.
  • 96
    Sun L, Adebanjo OA, Koval A, Anandatheerthavarada HK, Iqbal J, Wu XY, Moonga BS, Wu XB, Biswas G, Bevis PJ et al. (2002) A novel mechanism for coupling cellular intermediary metabolism to cytosolic Ca2+ signaling via CD38/ADP-ribosyl cyclase, a putative intracellular NAD+ sensor. FASEB J 16, 302314.
  • 97
    Avalos JL, Bever KM & Wolberger C (2005) Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Mol Cell 17, 855868.
  • 98
    Clark JB, Ferris GM & Pinder S (1971) Inhibition of nuclear NAD nucleosidase and poly ADP-ribose polymerase activity from rat liver by nicotinamide and 5'-methyl nicotinamide. Biochim Biophys Acta 238, 8285.
  • 99
    Mueller-Dieckmann C, Kernstock S, Lisurek M, von Kries JP, Haag F, Weiss MS & Koch-Nolte F (2006) The structure of human ADP-ribosylhydrolase 3 (ARH3) provides insights into the reversibility of protein ADP-ribosylation. Proc Natl Acad Sci U S A 103, 1502615031.
  • 100
    Zharova TV & Vinogradov AD (1997) A competitive inhibition of the mitochondrial NADH-ubiquinone oxidoreductase (complex I) by ADP-ribose. Biochim Biophys Acta 1320, 256264.
  • 101
    Ayub K & Hallett MB (2004) The mitochondrial ADPR link between Ca2+ store release and Ca2+ influx channel opening in immune cells. FASEB J 18, 13351338.
  • 102
    Perraud AL, Takanishi CL, Shen B, Kang S, Smith MK, Schmitz C, Knowles HM, Ferraris D, Li W, Zhang J et al. (2005) Accumulation of free ADP-ribose from mitochondria mediates oxidative stress-induced gating of TRPM2 cation channels. J Biol Chem 280, 61386148.
  • 103
    Perraud AL, Fleig A, Dunn CA, Bagley LA, Launay P, Schmitz C, Stokes AJ, Zhu Q, Bessman MJ, Penner R et al. (2001) ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology. Nature 411, 595599.
  • 104
    Sano Y, Inamura K, Miyake A, Mochizuki S, Yokoi H, Matsushime H & Furuichi K (2001) Immunocyte Ca2+ influx system mediated by LTRPC2. Science 293, 13271330.
  • 105
    Grubisha O, Rafty LA, Takanishi CL, Xu X, Tong L, Perraud AL, Scharenberg AM & Denu JM (2006) Metabolite of SIR2 reaction modulates TRPM2 ion channel. J Biol Chem 281, 1405714065.
  • 106
    Oka S, Kato J & Moss J (2006) Identification and characterization of a mammalian 39-kDa poly(ADP-ribose) glycohydrolase. J Biol Chem 281, 705713.
  • 107
    Neuvonen M & Ahola T (2009) Differential activities of cellular and viral macro domain proteins in binding of ADP-ribose metabolites. J Mol Biol 385, 212225.
  • 108
    Chen D, Vollmar M, Rossi MN, Phillips C, Kraehenbuehl R, Slade D, Mehrotra PV, von Delft F, Crosthwaite SK, Gileadi O et al. (2011) Identification of macrodomain proteins as novel O-acetyl-ADP-ribose deacetylases. J Biol Chem 286, 1326113271.
  • 109
    Han W, Li X & Fu X (2011) The macro domain protein family: structure, functions, and their potential therapeutic implications. Mutat Res 727, 86103.
  • 110
    McLennan AG (2006) The Nudix hydrolase superfamily. Cell Mol Life Sci 63, 123143.
  • 111
    Mildvan AS, Xia Z, Azurmendi HF, Saraswat V, Legler PM, Massiah MA, Gabelli SB, Bianchet MA, Kang LW & Amzel LM (2005) Structures and mechanisms of Nudix hydrolases. Arch Biochem Biophys 433, 129143.
  • 112
    Bernet D, Pinto RM, Costas MJ, Canales J & Cameselle JC (1994) Rat liver mitochondrial ADP-ribose pyrophosphatase in the matrix space with low Km for free ADP-ribose. Biochem J 299 (Pt 3), 679682.
  • 113
    Perraud AL, Shen B, Dunn CA, Rippe K, Smith MK, Bessman MJ, Stoddard BL & Scharenberg AM (2003) NUDT9, a member of the Nudix hydrolase family, is an evolutionarily conserved mitochondrial ADP-ribose pyrophosphatase. J Biol Chem 278, 17941801.
  • 114
    Shen BW, Perraud AL, Scharenberg A & Stoddard BL (2003) The crystal structure and mutational analysis of human NUDT9. J Mol Biol 332, 385398.
  • 115
    Yang H, Slupska MM, Wei YF, Tai JH, Luther WM, Xia YR, Shih DM, Chiang JH, Baikalov C, Fitz-Gibbon S et al. (2000) Cloning and characterization of a new member of the Nudix hydrolases from human and mouse. J Biol Chem 275, 88448853.
  • 116
    Pittelli M, Formentini L, Faraco G, Lapucci A, Rapizzi E, Cialdai F, Romano G, Moneti G, Moroni F & Chiarugi A (2010) Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool. J Biol Chem 285, 3410634114.
  • 117
    Yang H, Yang T, Baur JA, Perez E, Matsui T, Carmona JJ, Lamming DW, Souza-Pinto NC, Bohr VA, Rosenzweig A et al. (2007) Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130, 10951107.
  • 118
    Todisco S, Agrimi G, Castegna A & Palmieri F (2006) Identification of the mitochondrial NAD+ transporter in Saccharomyces cerevisiae. J Biol Chem 281, 15241531.
  • 119
    Palmieri F, Rieder B, Ventrella A, Blanco E, Do PT, Nunes-Nesi A, Trauth AU, Fiermonte G, Tjaden J, Agrimi G et al. (2009) Molecular identification and functional characterization of Arabidopsis thaliana mitochondrial and chloroplastic NAD+ carrier proteins. J Biol Chem 284, 3124931259.
  • 120
    Titus SA & Moran RG (2000) Retrovirally mediated complementation of the glyB phenotype. Cloning of a human gene encoding the carrier for entry of folates into mitochondria. J Biol Chem 275, 3681136817.
  • 121
    Spaan AN, Ijlst L, van Roermund CW, Wijburg FA, Wanders RJ & Waterham HR (2005) Identification of the human mitochondrial FAD transporter and its potential role in multiple acyl-CoA dehydrogenase deficiency. Mol Genet Metab 86, 441447.
  • 122
    Zhang X, Kurnasov OV, Karthikeyan S, Grishin NV, Osterman AL & Zhang H (2003) Structural characterization of a human cytosolic NMN/NaMN adenylyltransferase and implication in human NAD biosynthesis. J Biol Chem 278, 1350313511.
  • 123
    Nikiforov A, Dolle C, Niere M & Ziegler M (2011) Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J Biol Chem 286, 2176721778.
  • 124
    Lau C, Niere M & Ziegler M (2009) The NMN/NaMN adenylyltransferase (NMNAT) protein family. Front Biosci 14, 410431.
  • 125
    Magni G, Amici A, Emanuelli M, Orsomando G, Raffaelli N & Ruggieri S (2004) Structure and function of nicotinamide mononucleotide adenylyltransferase. Curr Med Chem 11, 873885.
  • 126
    Barile M, Passarella S, Danese G & Quagliariello E (1996) Rat liver mitochondria can synthesize nicotinamide adenine dinucleotide from nicotinamide mononucleotide and ATP via a putative matrix nicotinamide mononucleotide adenylyltransferase. Biochem Mol Biol Int 38, 297306.
  • 127
    Formentini L, Moroni F & Chiarugi A (2009) Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo. Biochem Pharmacol 77, 16121620.